What happens when you take matcha with warfarin?
Matcha is finely powdered whole green tea leaf. Unlike brewed sencha or bancha, where most of the leaf is discarded after steeping, matcha is whisked into water and the entire leaf is consumed. That changes how much vitamin K reaches you, and vitamin K is exactly what warfarin is dosed against.
- Matcha delivers whole-leaf vitamin K. Because you swallow the powdered leaf rather than discarding it, a serving of matcha provides more vitamin K than the small fraction that leaches into a cup of brewed green tea. Matcha lattes and matcha-based drinks add more leaf, and so more vitamin K.
- Vitamin K opposes warfarin. Warfarin (Coumadin, Jantoven) works by blocking vitamin K epoxide reductase in the liver, which lowers active vitamin K and reduces production of clotting factors II, VII, IX, and X.
- More dietary vitamin K means more clotting factors. When vitamin K intake rises, the liver makes more clotting factors, the international normalised ratio (INR) falls, and the anticoagulant effect of warfarin weakens.
- Stopping has the opposite effect. If you suddenly drop a regular matcha habit, vitamin K intake falls, INR can climb, and the anticoagulant effect can become stronger than intended.
A published case report on green tea and warfarin describes a patient whose INR fell below his target range after he began drinking very large daily volumes of green tea, then recovered after he stopped. Matcha is whole-leaf rather than brewed, so it can contribute to the same kind of shift.
Why is this important?
Warfarin has a narrow therapeutic window. When INR drops below target, the risk of stroke, deep vein thrombosis, pulmonary embolism, and valve thrombosis rises. When INR overshoots, the risk of major bleeding, including gastrointestinal and intracranial haemorrhage, rises.
Because warfarin is dosed against an INR that depends partly on dietary vitamin K, the central principle of warfarin diet management is consistency. Patients are taught to keep their intake of leafy greens, broccoli, and other vitamin-K-rich foods roughly steady from week to week rather than to avoid them entirely. The same applies to matcha. Starting a new daily matcha habit after months of stable INRs can let INR drift below target, and suddenly stopping a daily habit can let it rise above target.
This is easy to miss because most people do not think of matcha as a medication-relevant change. The relevant factor is the whole-leaf vitamin K, which makes matcha worth flagging more than an occasional cup of brewed green tea, and the same logic applies to matcha extracts and ready-to-drink matcha lattes.
What should you do?
The practical rule is simple: keep matcha intake small and steady, and never change it silently.
Before you change anything: Tell your anticoagulation clinic before you start, stop, or scale a matcha habit. They can plan an INR check around the change instead of being surprised by a drift later.
Every day, if you have matcha at all: Aim for a small, consistent serving at the same time each day rather than several large servings on some days and none on others. Consistency matters more than the exact amount. Taking matcha at a different time of day from your warfarin dose does not solve the problem, because the interaction is pharmacodynamic and plays out over days, not minutes; total daily intake and week-to-week steadiness are what move INR. Timing a few hours apart neither helps nor hurts here.
After a change: Ask for an INR check in the days to couple of weeks after starting or stopping a matcha habit, so any drift in either direction is caught early and your dose can be adjusted if needed.
Avoid matcha-based weight-loss regimens and concentrated matcha shots, which can deliver a lot of powdered leaf. Also be cautious with green tea extract or matcha extract capsules. If you are switching from warfarin to a direct oral anticoagulant (apixaban, rivaroxaban, edoxaban, or dabigatran), this particular interaction no longer applies, because those medicines do not depend on vitamin K. Review any of this with your doctor or pharmacist.
Which specific products are affected?
The interaction is with warfarin (Coumadin, Jantoven) and other coumarin anticoagulants such as acenocoumarol and phenprocoumon. Direct oral anticoagulants (apixaban, rivaroxaban, edoxaban, dabigatran) are not affected.
Matcha-containing products to watch include:
- Ceremonial-grade matcha
- Culinary-grade matcha
- Cafe-made and ready-to-drink matcha lattes
- Matcha smoothies
- Matcha-flavoured energy bars and protein powders
- Matcha ice cream
- Matcha-containing weight-loss supplements
- Green tea extract and matcha extract capsules
Standard brewed green tea is lower-risk per cup but still counts toward your overall vitamin K intake.
The science behind it
The clearest human evidence is the case report by Taylor and Wilt (Annals of Pharmacotherapy, 1999), which describes a warfarin patient whose INR fell below his target range after he started drinking very large daily volumes of green tea and recovered after he stopped. This established green tea as a plausible source of vitamin K capable of antagonising warfarin.
A systematic summary by inPharmD reviewing whether matcha (green tea) interacts with warfarin classifies it as a moderate, vitamin-K-mediated interaction and advises keeping intake consistent rather than avoiding it outright. The Drugs.com interaction monograph for warfarin and green tea similarly notes the vitamin K content and the potential for reduced anticoagulant effect.
It is worth being honest about the limits here: the direct human data is for green tea, not matcha specifically. The extension to matcha is a reasonable inference from the fact that matcha is whole, powdered leaf and so carries more vitamin K per serving, but it is an inference rather than a matcha-specific trial. The direction (matcha can lower INR and weaken warfarin) and the moderate severity are well supported; the magnitude in any individual depends on dose and consistency.
Frequently Asked Questions
Can I drink matcha at all if I take warfarin?
Usually yes, as long as you keep it small and consistent and tell your anticoagulation clinic. The danger is fluctuation, not the existence of matcha in your diet.
Does taking matcha hours apart from my warfarin dose avoid the problem?
No. The interaction works through vitamin K and clotting-factor synthesis over days, not through timing within a single day. Spacing the two a few hours apart does not change the effect; consistency of total daily intake is what matters.
Is matcha riskier than ordinary brewed green tea?
Per serving, generally yes, because matcha is whole powdered leaf and you consume the vitamin K that brewing would otherwise leave behind. Brewed green tea still counts toward your overall intake, but each cup contributes less.
What about green tea or matcha extract capsules?
Be cautious. Concentrated extracts can contribute vitamin K and are easy to start or stop abruptly, which is exactly the kind of change that can move your INR. Discuss them with your pharmacist before using them.
I just stopped my daily matcha. Should I be worried?
Stopping can let your INR rise, which can increase bleeding risk. Let your anticoagulation clinic know and ask whether an INR check is warranted.
Does this apply if I take a DOAC instead of warfarin?
No. Apixaban, rivaroxaban, edoxaban, and dabigatran do not depend on vitamin K, so the matcha-vitamin K interaction does not apply to them.
Key takeaways
- Matcha is whole powdered green tea leaf and delivers more vitamin K per serving than brewed green tea.
- Vitamin K opposes warfarin, so starting or increasing matcha can lower INR and weaken anticoagulation; stopping it can raise INR.
- Consistency is the rule: keep any intake small and steady, and never change it silently.
- Tell your anticoagulation clinic before any change and ask for an INR check afterward.
- Be cautious with matcha-based weight-loss products and green tea or matcha extract capsules.
- This interaction does not apply to direct oral anticoagulants (apixaban, rivaroxaban, edoxaban, dabigatran).